Work by Prince and colleagues in 2007 was the first to identify a subpopulation of HNSCC tumor cells with stem cell-like phenotypes, initially using the cellular marker CD44 (Prince et al., 2007). Here, CD44 is linked to head and neck squamous cell carcinoma.